SUBSCRIBE
SUBSCRIBE
News   Business

Angel Biotechnology Ltd to Sell Cramlington Facility, Concentrate Output at Pentlands

June 27, 2007 | 
1 min read
LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said, following the increased cost burden at its Cramlington facility near Newcastle, it has decided to close and sell it and concentrate production at its Pentlands, Edinburgh, facility.
Real estate Europe
MORE ON THIS TOPIC
Paint roller in cartoon style. 3D background. Vector illustration.
C-suite
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
September 14, 2026
 · 
3 min read
 · 
Annalee Armstrong
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.
Venture capital
Frazier adds $1.1B+ to small and mid-sized biotech fund
September 11, 2026
 · 
2 min read
 · 
Tristan Manalac
Business people and concepts vector art exit
Business
Takeda’s long-term R&D head announces exit after major pipeline reorganization
September 10, 2026
 · 
2 min read
 · 
Gabrielle Masson